Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Capecitabine Capecitabine 150mg Film coated tablet REX Medical Limited Cipla Limited, Goa, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Capecitabine Capecitabine 500mg Film coated tablet REX Medical Limited Cipla Limited, Goa, India
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
m-Azithromycin Azithromycin dihydrate 262.05mg equivalent to Azithromycin 250mg Film coated tablet Multichem NZ Limited Sunshine Lake Pharma Co. Limited, GuanDong Province, China
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
m-Azithromycin Azithromycin dihydrate 524.1mg equivalent to Azithromycin 500mg Film coated tablet Multichem NZ Limited Sunshine Lake Pharma Co. Limited, GuanDong Province, China
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Rabipur Rabies vaccine 2.5IU Injection with diluent bioCSL (NZ) Limited Novartis Vaccines & Diagnostics GmBH & Co KG, Marburg, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Xalkori Crizotinib 200mg Capsule, powder filled Pfizer New Zealand Limited Pfizer Manufacturing Deutschland GmbH, Freiburg, Germany
|
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:
|
Xalkori Crizotinib 250mg Capsule, powder filled Pfizer New Zealand Limited Pfizer Manufacturing Deutschland GmbH, Freiburg, Germany
|
Dated this 20th day of February 2015.
SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).